Focusing on oligomeric tau as a therapeutic target in Alzheimer's disease and other tauopathies

Rayman, J. B. (2023). Focusing on oligomeric tau as a therapeutic target in Alzheimer’s disease and other tauopathies. Expert Opinion on Therapeutic Targets, 27(4–5), 269–279. https://doi.org/10.1080/14728222.2023.2206561
Authors:
Joseph B Rayman
Affiliated Authors:
Joseph B Rayman
Columbia Affiliation:
Subjects:
Alzheimer Disease (MeSH)
Supranuclear Palsy, Progressive (MeSH)
Tauopathies (MeSH)
Author Keywords:
alzheimer’s disease
frontotemporal dementia
neurodegeneration
oligomeric tau
progressive supranuclear palsy
tau
tauopathies
therapeutics
elink
Publication Type:
Article
Unique ID:
10.1080/14728222.2023.2206561
PMID:
37140480
DOI:
10.1080/14728222.2023.2206561
Journal:
Expert Opinion on Therapeutic Targets
Publication Date:
Data Source:
PubMed
Source Link:
View PubMed Record

Record Created: